KR102802503B1 - 갈렉틴-3 억제제로서의 테트라히드로피란-기재 티오디사카라이드 모방체 - Google Patents

갈렉틴-3 억제제로서의 테트라히드로피란-기재 티오디사카라이드 모방체 Download PDF

Info

Publication number
KR102802503B1
KR102802503B1 KR1020217000905A KR20217000905A KR102802503B1 KR 102802503 B1 KR102802503 B1 KR 102802503B1 KR 1020217000905 A KR1020217000905 A KR 1020217000905A KR 20217000905 A KR20217000905 A KR 20217000905A KR 102802503 B1 KR102802503 B1 KR 102802503B1
Authority
KR
South Korea
Prior art keywords
pyran
mmol
triazol
tetrahydro
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020217000905A
Other languages
English (en)
Korean (ko)
Other versions
KR20210021015A (ko
Inventor
리처드 에이. 하르츠
리 수
데이비드 에스. 윤
앨리샤 레게이로-렌
프라사다 라오 잘라감
마노란잔 판다
사티쉬 케사반 나이르
Original Assignee
브리스톨-마이어스 스큅 컴퍼니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 브리스톨-마이어스 스큅 컴퍼니 filed Critical 브리스톨-마이어스 스큅 컴퍼니
Publication of KR20210021015A publication Critical patent/KR20210021015A/ko
Application granted granted Critical
Publication of KR102802503B1 publication Critical patent/KR102802503B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/02—Heterocyclic radicals containing only nitrogen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
KR1020217000905A 2018-06-15 2019-06-13 갈렉틴-3 억제제로서의 테트라히드로피란-기재 티오디사카라이드 모방체 Active KR102802503B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862685395P 2018-06-15 2018-06-15
US62/685,395 2018-06-15
US201962831867P 2019-04-10 2019-04-10
US62/831,867 2019-04-10
PCT/US2019/036877 WO2019241461A1 (en) 2018-06-15 2019-06-13 Tetrahydropyran-based thiodisaccharide mimics as galectin-3 inhibitors

Publications (2)

Publication Number Publication Date
KR20210021015A KR20210021015A (ko) 2021-02-24
KR102802503B1 true KR102802503B1 (ko) 2025-04-29

Family

ID=67297250

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020217000905A Active KR102802503B1 (ko) 2018-06-15 2019-06-13 갈렉틴-3 억제제로서의 테트라히드로피란-기재 티오디사카라이드 모방체

Country Status (7)

Country Link
US (1) US11970511B2 (https=)
EP (1) EP3807290B1 (https=)
JP (1) JP7190513B2 (https=)
KR (1) KR102802503B1 (https=)
CN (1) CN112292386B (https=)
ES (1) ES2912499T3 (https=)
WO (1) WO2019241461A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113366007A (zh) * 2018-10-15 2021-09-07 格莱克特生物技术公司 半乳糖凝集素的半乳糖苷抑制剂
JP2022508719A (ja) * 2018-10-15 2022-01-19 ガレクト バイオテック エービー ガレクチンのガラクトシド阻害剤のプロドラッグ
KR20230006547A (ko) * 2020-05-05 2023-01-10 브리스톨-마이어스 스큅 컴퍼니 갈렉틴-3의 소분자 억제제
EP4157833A1 (en) 2020-05-28 2023-04-05 Bristol-Myers Squibb Company Galectin-3 inhibitors

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010126435A1 (en) 2009-04-28 2010-11-04 Forskarpatent I Syd Ab Novel galactoside inhibitors of galectins
WO2016005311A1 (en) 2014-07-09 2016-01-14 Galecto Biotech Ab Novel hybrid galactoside inhibitor of galectins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0401301D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel 3-triazolyl-galactoside inhibitors of galectins
SE0401300D0 (sv) 2004-05-21 2004-05-21 Forskarpatent I Syd Ab Novel Galactoside Inhibitors of Galectins
US20140243302A1 (en) 2011-06-27 2014-08-28 Merck Sharp & Dohme Corporation Bridged bicyclic compounds for the treatment of bacterial infections
US9021050B2 (en) 2012-08-31 2015-04-28 Yume, Inc. Network service system and method with off-heap caching
US8828971B2 (en) 2012-10-10 2014-09-09 Galectin Therapeutics, Inc. Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders
JP2015535233A (ja) * 2012-10-31 2015-12-10 ガレクト・バイオテック・エイビイ ガレクチン−３のガラクトシド阻害剤及び肺線維症のためのその使用
WO2014078655A1 (en) 2012-11-15 2014-05-22 Tufts University Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitor
JP6904906B2 (ja) 2015-01-30 2021-07-21 ガレクト・バイオテック・エイビイ ガレクチンの新規なガラクトシド阻害剤
ES2921500T3 (es) 2015-11-09 2022-08-26 Galecto Biotech Ab 1,1'-sulfanodiil-di-beta-d-galactopiranósidos como inhibidores de galectinas
JP6844991B2 (ja) 2015-11-10 2021-03-17 サンコ テキスタイル イスレットメレリ サン ベ ティク エーエスＳａｎｋｏ Ｔｅｋｓｔｉｌ Ｉｓｌｅｔｍｅｌｅｒｉ Ｓａｎ． Ｖｅ Ｔｉｃ． Ａ．Ｓ． ジッパーを有する伸縮性衣類の製法

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010126435A1 (en) 2009-04-28 2010-11-04 Forskarpatent I Syd Ab Novel galactoside inhibitors of galectins
WO2016005311A1 (en) 2014-07-09 2016-01-14 Galecto Biotech Ab Novel hybrid galactoside inhibitor of galectins

Also Published As

Publication number Publication date
CN112292386B (zh) 2024-06-11
JP7190513B2 (ja) 2022-12-15
KR20210021015A (ko) 2021-02-24
EP3807290B1 (en) 2022-03-30
WO2019241461A1 (en) 2019-12-19
EP3807290A1 (en) 2021-04-21
CN112292386A (zh) 2021-01-29
US20210323991A1 (en) 2021-10-21
JP2021527102A (ja) 2021-10-11
US11970511B2 (en) 2024-04-30
ES2912499T3 (es) 2022-05-26

Similar Documents

Publication Publication Date Title
US11072626B2 (en) Small molecule inhibitors of Galectin-3
KR102802503B1 (ko) 갈렉틴-3 억제제로서의 테트라히드로피란-기재 티오디사카라이드 모방체
US11267811B2 (en) Small molecule inhibitors of galectin-3
JP6353922B2 (ja) チオヌクレオシド誘導体またはその塩および医薬組成物
KR20220071193A (ko) Kras g12d 억제제
TWI785474B (zh) 用作選擇性Aurora A抑制劑的新型雜環化合物
US12275719B2 (en) Small molecule inhibitors of galectin-3
KR20180094514A (ko) 브루톤 티로신 키나제 억제제 및 이의 사용 방법
CN113874354A (zh) 吡啶酮类衍生物、其制备方法及其在医药上的应用
JP2020015664A (ja) 含窒素多環式ヘテロ環誘導体
WO2022066917A1 (en) 3-(6-aminopyridin-3-yl)benzamide derivatives as ripk2 inhibitors
CN115551855A (zh) 半乳凝素-3的小分子抑制剂
JP2023524033A (ja) フェロポルチン阻害剤としてのシクロアルキルピリミジン
US12275718B2 (en) Small molecule inhibitors of galectin-3
KR20250148620A (ko) 이민 화합물 및 이의 제조 방법과 용도
HK1235794A1 (en) Thionucleoside derivative or salt thereof, and pharmaceutical composition

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20210112

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20220613

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20240821

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20250422

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20250425

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20250425

End annual number: 3

Start annual number: 1

PG1601 Publication of registration